Advanced Medical Solutions Group (LON:AMS) Insider A Christopher (Chris) Meredith Sells 50,510 Shares of Stock

Advanced Medical Solutions Group plc (LON:AMS) insider A Christopher (Chris) Meredith sold 50,510 shares of Advanced Medical Solutions Group stock in a transaction dated Wednesday, September 24th. The shares were sold at an average price of GBX 218, for a total value of £110,111.80.

Advanced Medical Solutions Group Stock Performance

Shares of AMS opened at GBX 211.50 on Friday. The company’s fifty day moving average is GBX 206.28 and its 200-day moving average is GBX 203.36. Advanced Medical Solutions Group plc has a 12 month low of GBX 168.40 and a 12 month high of GBX 242. The firm has a market cap of £457.12 million, a price-to-earnings ratio of 6,507.69, a price-to-earnings-growth ratio of 5.00 and a beta of 0.74. The company has a quick ratio of 4.58, a current ratio of 8.39 and a debt-to-equity ratio of 37.01.

Advanced Medical Solutions Group (LON:AMS) last released its quarterly earnings data on Wednesday, September 17th. The company reported GBX 5.77 earnings per share (EPS) for the quarter. Advanced Medical Solutions Group had a net margin of 8.49% and a return on equity of 4.57%. Equities analysts expect that Advanced Medical Solutions Group plc will post 9.8159509 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

AMS has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 275 price objective on shares of Advanced Medical Solutions Group in a research note on Wednesday, July 16th. Peel Hunt reiterated a “buy” rating and issued a GBX 246 target price on shares of Advanced Medical Solutions Group in a report on Wednesday, September 17th. Finally, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 300 price target on shares of Advanced Medical Solutions Group in a research report on Wednesday, September 17th. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of GBX 273.67.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.